SRPT:NASDAQ
Sarepta Therapeutics Inc
$17.31
arrow_downward
-1.03%(-0.18) 1D
$17.30
arrow_downward
-0.06% (-0.010)bedtimeAfter hours
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SRPT...
Open
$17.60
High
$17.65
Low
$17.04
Mkt. cap
1.83B
Avg. vol.
2.97M
Volume
0.00
52-wk high
$25.32
52-wk low
$14.68
EPS
-$1.66
Beta
0.38
Shares outstanding
105.63M
No. of employees
835
Open
$17.60
High
$17.65
Low
$17.04
Mkt. cap
1.83B
Avg. vol.
2.97M
Volume
0.00
52-wk high
$25.32
52-wk low
$14.68
EPS
-$1.66
Beta
0.38
Shares outstanding
105.63M
No. of employees
835
News stories
From web sources and news partners
AD HOC NEWS
·
1 hour ago
Sarepta Therapeutics stock faces a USD 5.00 Sell target
AD HOC NEWS
·
7 hours ago
HC Wainwright reiterates Sell for Sarepta Therapeutics stock
Benzinga
·
18 hours ago
Jim Cramer: This Tech Stock Is 'Very Good,' Avery Dennison Is A ‘Winner’
Simply Wall Street
·
1 day ago
Two Stories Ran On Sarepta Therapeutics. Only One Held Up
Profile
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Inc